SpringWorks Therapeutics Statistics

Total Valuation

Grace Breeding has a market cap or net worth of ILS 92.43 million. The enterprise value is 90.23 million.

Market Cap	92.43M
Enterprise Value	90.23M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Grace Breeding has 4.14 million shares outstanding. The number of shares has increased by 11.21% in one year.

Current Share Class	4.14M
Shares Outstanding	4.14M
Shares Change (YoY)	+11.21%
Shares Change (QoQ)	+3.14%
Owned by Insiders (%)	74.96%
Owned by Institutions (%)	0.79%
Float	1.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,359.23
PB Ratio	258.18
P/TBV Ratio	54.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-36.50
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.34

Current Ratio	2.34
Quick Ratio	1.84
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-31.74

Financial Efficiency

Return on equity (ROE) is -648.83% and return on invested capital (ROIC) is -253.91%.

Return on Equity (ROE)	-648.83%
Return on Assets (ROA)	-94.21%
Return on Invested Capital (ROIC)	-253.91%
Return on Capital Employed (ROCE)	-408.33%
Revenue Per Employee	17,000
Profits Per Employee	-618,000
Employee Count	4
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +51.29% in the last 52 weeks. The beta is 0.72, so Grace Breeding's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	+51.29%
50-Day Moving Average	1,946.22
200-Day Moving Average	1,463.56
Relative Strength Index (RSI)	65.28
Average Volume (20 Days)	1,920

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Grace Breeding had revenue of ILS 68,000 and -2.47 million in losses. Loss per share was -0.63.

Revenue	68,000
Gross Profit	39,000
Operating Income	-2.79M
Pretax Income	-2.78M
Net Income	-2.47M
EBITDA	-2.78M
EBIT	-2.79M
Loss Per Share	-0.63

Full Income Statement

Balance Sheet

The company has 874,000 in cash and n/a in debt, giving a net cash position of 874,000 or 0.21 per share.

Cash & Cash Equivalents	874,000
Total Debt	n/a
Net Cash	874,000
Net Cash Per Share	0.21
Equity (Book Value)	358,000
Book Value Per Share	0.42
Working Capital	672,000

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.89M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	57.35%
Operating Margin	-4,107.35%
Pretax Margin	-4,083.82%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Grace Breeding does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.21%
Shareholder Yield	n/a
Earnings Yield	-2.67%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Grace Breeding has an Altman Z-Score of -22.94 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-22.94
Piotroski F-Score	3